In bullous pemphigoid, the subepidermal blister forms as a result of which immunological mechanism?

Explanation

## Pathogenic Mechanism of Blister Formation in Bullous Pemphigoid **Key Point:** Bullous pemphigoid blisters form via complement-mediated inflammation at the dermal–epidermal junction (DEJ), not direct cell lysis or acantholysis. ### Step-by-Step Pathogenesis 1. **Autoantibody Binding**: IgG and IgM antibodies bind to BP180 and BP230 at the hemidesmosomal BMZ 2. **Complement Activation**: Antibody–antigen complexes activate the classical complement cascade 3. **C3 Deposition**: C3b and C3a are generated; C3a acts as a potent chemotactic factor 4. **Cellular Recruitment**: Mast cells and neutrophils are recruited to the BMZ 5. **Enzyme Release**: Mast cells release tryptase and heparin; neutrophils release collagenase, elastase, and other serine proteases 6. **Basement Membrane Disruption**: Proteolytic enzymes degrade collagen IV and other BMZ components 7. **Blister Formation**: Subepidermal blister forms *above* the basal lamina (at the level of the lamina lucida) ### Immunofluorescence Findings **High-Yield:** Direct immunofluorescence (DIF) on perilesional skin shows: - **Linear IgG deposition** along the basement membrane zone - **Linear C3 deposition** (often more prominent than IgG) - Pattern is continuous and uniform, outlining the DEJ ```mermaid flowchart TD A[IgG/IgM antibodies bind BP180/BP230]:::outcome A --> B[Classical complement pathway activated]:::action B --> C[C3a, C5a generated]:::outcome C --> D[Mast cells and neutrophils recruited]:::action D --> E[Release of proteolytic enzymes]:::action E --> F[Degradation of BMZ collagen]:::action F --> G[Subepidermal blister formation]:::outcome ``` ### Contrast with Pemphigus Vulgaris | Mechanism | Bullous Pemphigoid | Pemphigus Vulgaris | |-----------|-------------------|-------------------| | **Primary Pathology** | Complement-mediated inflammation | Antibody-mediated acantholysis | | **Blister Level** | Subepidermal (below epidermis) | Intraepidermal (within epidermis) | | **Cell Death Mechanism** | Enzymatic degradation of BMZ | Loss of cell–cell adhesion (desmoglein) | | **DIF Pattern** | Linear at BMZ | Intercellular ("tombstone") | | **Complement Role** | Central | Minor or absent | **Clinical Pearl:** The presence of prominent C3 deposition (sometimes even more intense than IgG) on DIF is a clue to the complement-driven pathogenesis and helps distinguish BP from other blistering disorders.